Lantus
Ailment: Diabetes
2014 U.S. Sales: $5.6 billion
Owner: Sanofi
Sales of this insulin have skyrocketed as the rates of obesity and diabetes in the United States have risen in recent years. Sanofi recently filed a lawsuit against competitor Eli Lilly, claiming that an in-development rival insulin drug infringes on Sanofi’s intellectual property.
